Biden Administration Rethinks Medicare Negotiation

Democratic attempts to curb drug prices have been hindered by conflict within the party as well as external lobbying by pharma. Now, pricing negotiation by Medicare may be off the table.

“President Joe Biden has jettisoned a raft of policy proposals aimed at curbing the price of prescription medicines as part of the US administration’s $1.75 trillion ‘build back better’ framework.” Read more here.

(Source: Phil Taylor, Pharmaphorum, 10/29/21)